05.05.25 -- From Lab To Launch: Smarter Strategies, Faster Trials, And Future Technologies

Explore the advancing mass spectrometry, biophysical characterization, automated sample preparation, and high throughput analytics required to deliver medicines in a safe, compliant, and efficient manner.

Assessing outsourcing partners’ credentials in people, technology, supply chains, and integration will make all the difference as sponsors aim to streamline processes on the path to commercialization.

These studies validate cleaning protocols in pharma facilities, ensuring regulatory compliance, reducing contamination risk, and supporting safe, effective disinfection with expert CRO guidance.

When viewing a CDMO as merely a service provider, interactions are often limited to completing tasks. This mindset can stifle innovation and problem-solving.

While clinical efficacy is the critical benchmark for any drug program, ensuring manufacturability is also vital. An experienced CDMO can help you establish efficient and cost-effective production strategies.

Review some of the key considerations in cell line development, how advances in technology are improving the efficiency and productivity of cell lines, and the future of cell line development.

Choose a flexible and experienced CDMO to ensure seamless scalability, diverse process capabilities, and expert analytical support for your microbial protein production.

This research demonstrates the potential of high-pressure sterile filtration to enhance efficiency, reduce waste, and accelerate the development of innovative therapies.

A sponsor’s commitment to impurity control throughout manufacturing is vital to ensuring continuous patient safety. E&Ls, nitrosamines, and PFAS are among the most critical impurities to test for.

For many bioprocessing applications, artificial intelligence (AI) and machine learning (ML) can be used in every phase of development to support optimization and streamline repetitive, effort-intensive processes.

Discover how CDMOs can help you achieve and maintain CMC compliance throughout the drug development lifecycle. Outsourced Pharma Live will explore how to leverage CDMO expertise in process optimization, documentation, and regulatory submissions. Learn practical strategies to align your CMC goals with CDMO capabilities to accelerate development and ensure successful drug launches. Registration is free thanks to the support of Curia.

Your partner in contract production and development using the end-to-end business model. We specialize in the production of sterile biotechnological products in a manufacturing plant that meets GMP requirements.

Argonaut features state-of-the-art automated equipment for high-yield filling of sterile injectable drugs. Projects are supported by a full analytical quality control service offering, warehousing, and global shipping logistics. Equipped with advanced robotics, our automated fill line is specially designed to maximize product yield while minimizing the risks associated with operator intervention.

Singota has key partnerships to better serve clients. Singota works alongside Modality Solutions to provide clients insight into potential product degradation inflicted during the final product distribution process and provide transport validation support by utilizing Modality's Transport Simulation Laboratory (TSL).

Backed by Lonza’s more than 30 years’ expe­rience and expertise in biological processing and our track record in the chemical and bio­technological industry, we offer our customers a full “one-stop-shop” service package at all stages of development and production.

As a fully integrated CDMO, we offer a comprehensive suite of services, from early-stage research to robust commercial manufacturing, within our state-of-the-art facilities.